NCT06359457

Brief Summary

This study will be conducted to determine the correlation between the levels of serum progesterone and Menstrual Symptoms In Young Females with primary dysmenorrhea.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 30, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 11, 2024

Completed
24 days until next milestone

Study Start

First participant enrolled

May 5, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2024

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

January 29, 2025

Status Verified

April 1, 2024

Enrollment Period

7 months

First QC Date

March 30, 2024

Last Update Submit

January 27, 2025

Conditions

Keywords

DysmenorrhoeaSerum progesterone levelVisual analogue scaleMenstrual symptoms questionnaire

Outcome Measures

Primary Outcomes (5)

  • Serum progesterone level

    Blood samples will be taken by physician for each girl, and will send to laboratory center to measure the progesterone level in the blood. The normal serum progesterone level at 21st day is 4-20 ng

    1 month

  • Pain intensity

    It will be measured by Visual analogue scale. It is 10 cm line with values ranging from 0 to 10. 0 indicates no pain nd 10 indicates the worst pain.

    1 month

  • Physical and psychological menstrual symptoms

    It will be measured by menstrual symptoms questionnaire. It is 25 items split into two categories which used to assess the physical and psychological symptoms associated with dysmenorrhea. The score on each item ranged from 1 (never) to 5 (always) with a higher composite score indicating more symptoms

    1 month

  • Correlation between serum progesterone level and pain

    The correlation between serum progesterone level and pain intensity measured by the VAS will be conducted

    1 month

  • Correlation between serum progesterone level and menstrual symptoms

    The correlation between serum progesterone level and menstrual symptoms measured by the menstrual symptom questionnaire will be conducted

    1 month

Study Arms (1)

A group of young females with primary dysmenorrhea

One hundred young females with primary dysmenorrhea will participate in this study. They will be recruited from the Gynecological outpatient clinic, Kasr El Ainy University Hospital, Cairo, Egypt. All females should have regular menstrual cycles. Taking blood samples of 3 ml through the cubital vein to examine the levels of serum progesterone will be carried out on the 21st day of menstruation, while to assess the pain intensity of primary dysmenorrhea using the Visual Analogue Scale (VAS) and physical and psychological symptoms associated with dysmenorrhea will be assessed by menstrual symptoms questionnaire .

Eligibility Criteria

Age17 Years - 25 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

One hundred girls with dysmenorrhoea. Menarche at least 3 years ago. All females should be regular menstrual cycles.

You may qualify if:

  • One hundreds adult females were suffered from primary dysmenorrhea.
  • Their age was ranged from 17 to 24 years.
  • Their body mass index was ranged from 20 to 25 kg/m2.

You may not qualify if:

  • Any participant will be excluded from the study if they have:
  • Irregulars or infrequent menstrual cycles.
  • Pacemaker, Myasthenia gravis, hyperthyroidism, active tuberculosis and psychosis.
  • Pelvic pathology.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Menna Allah Youssef Nasr El-Dien

Cairo, Egypt

Location

MeSH Terms

Conditions

Dysmenorrhea

Condition Hierarchy (Ancestors)

Menstruation DisturbancesPathologic ProcessesPathological Conditions, Signs and SymptomsPelvic PainPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • HANAA HAFEZ, PhD

    Lecturer of Physical Therapy for Orthopedic. Physical Therapy, Nahda University.

    STUDY DIRECTOR
  • RANIA Hamed, PhD

    Lecturer of Physical Therapy for Basic Science. Physical Therapy, Nahda University.

    STUDY DIRECTOR
  • ESRAA MOHAMED, PhD

    Lecturer Of Physical Therapy For Cardiovascular, Respiratory and Geriatrics.

    STUDY DIRECTOR
  • HOSSAM HUSSIEN, PhD

    Faculty of Medicine, Al-Azhar University.

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of physical therapy for women's health

Study Record Dates

First Submitted

March 30, 2024

First Posted

April 11, 2024

Study Start

May 5, 2024

Primary Completion

December 15, 2024

Study Completion

December 31, 2024

Last Updated

January 29, 2025

Record last verified: 2024-04

Locations